Prior immunisation of patients with malignant melanoma with vaccinia or BCG is associated with better survival. An European Organization for Research and Treatment of Cancer cohort study on 542 patients (Q34553710)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Prior immunisation of patients with malignant melanoma with vaccinia or BCG is associated with better survival. An European Organization for Research and Treatment of Cancer cohort study on 542 patients |
scientific article |
Statements
1 reference
Prior immunisation of patients with malignant melanoma with vaccinia or BCG is associated with better survival. An European Organization for Research and Treatment of Cancer cohort study on 542 patients (English)
1 reference
Gefeller O
1 reference
Kölmel KF
1 reference
Grange JM
1 reference
Krone B
1 reference
Mastrangelo G
1 reference
Rossi CR
1 reference
Henz BM
1 reference
Seebacher C
1 reference
Botev IN
1 reference
Niin M
1 reference
Lambert D
1 reference
Shafir R
1 reference
Kokoschka EM
1 reference
Kleeberg UR
1 reference
Pfahlberg A
1 reference
1 January 2005
1 reference
1 reference
41
1 reference
1
1 reference
118-125
1 reference
Identifiers
1 reference
1 reference